GlassScriptPhysician profile
David Reynolds
NPI 1467748558
$3,553.44
in general payments reported to CMS, 2019-2025
8 companies · $244 in 2025
The $244 reported for 2025 was less than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
See the full distribution for Vascular & Interventional Radiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $694 · 2020: $788 · 2021: $652 · 2022: $130 · 2023: $286 · 2024: $759 · 2025: $244.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,289.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,289.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,110.22 | 2019-2024 | Embold Fibered, Therasphere Y90 Glass Microspheres 10 Gbq |
| Sirtex Medical INC | $1,060.54 | 2019-2025 | Lava Les (Liquid Embolic System), Sir-Spheres Microspheres |
| Medtronic, INC. | $418.68 | 2021-2025 | Kyphon Express II Kyphopak Tray |
| Penumbra, INC. | $384.43 | 2020-2024 | Indigo System |
| Inari Medical, INC. | $290.24 | 2020 | |
| Medtronic USA, INC. | $188.76 | 2019 | |
| Trisalus Life Sciences, INC. | $77.00 | 2024 | Trinav Infusion System |
| Innovation Technologies INC | $23.57 | 2025 | Irrisept |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Reynolds listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.